Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 151 No. 2122 (2021)

Stroke management in a Swiss community hospital – in close collaboration with a stroke centre

  • Rolf Erlebach
  • Esther G. Gerrits
  • Michele Hess
  • Esther Bächli
DOI
https://doi.org/10.4414/smw.2021.20490
Cite this as:
Swiss Med Wkly. 2021;151:w20490
Published
07.06.2021

Summary

BACKGROUND

Despite the universal recognition that stroke is a major burden of public health in developed countries, little is known concerning its epidemiology and care outside of stroke centres. The objective of our study was to provide information concerning risk factors for stroke, stroke management and quality of care in a community hospital in Switzerland.

METHODS

Retrospective observational in-hospital study of adult stroke patients treated in a community hospital in Switzerland in collaboration with a nearby stroke centre. Patients were identified by the corresponding ICD-10 codes from July 2017 to December 2018.

RESULTS

We included 261 patients with a median age of 78 years (interquartile range [IQR] 68–85). Sixty-four percent (166) had ischaemic strokes, 18% (46) transient ischaemic attacks and 19% (49) intracranial bleeding. The most frequent risk factors were arterial hypertension in 195 (75%) patients, dyslipidaemia in 124 (48%) patients and overweight/obesity in 102 (39%). Dyslipidaemia and atrial fibrillation were undiagnosed at admission in 47 (38%) and 16 (27%) patients, respectively. Ninety-one (37%) patients with an out-of-hospital stroke presented within 4.5 hours after symptom onset. Intravenous thrombolysis was initiated in 27 patients (49% of the out-of-hospital ischaemic strokes presenting within 4.5 hours) and the median door-to-needle time was 55 minutes (IQR 40–67) and within 60 minutes in 16 (59%) patients. The most frequent poststroke complications were aspiration pneumonia in 22 (8%) followed by urinary tract infection in 14 (5%). The referral rate to a stroke centre or neurosurgical unit was 18%.

CONCLUSION

Our findings support further education of the population in recognition of stroke symptoms and assessment of cardiovascular risk factors according to guidelines. Telemedical cooperation with a local stroke centre can result in adequate quality of care in these patients.

References

  1. Meyer K, Simmet A, Arnold M, Mattle H, Nedeltchev K. Stroke events, and case fatalities in Switzerland based on hospital statistics and cause of death statistics. Swiss Med Wkly. 2009;139(5-6):65–9. doi:.https://doi.org/10.4414/smw.2009.12448
  2. Bundesamt für Statistik. Bilanz der ständigen Wohnbevölkerung, 1861-2018 [Internet]. [cited 2020 June 26]. Available from: https://www.bfs.admin.ch/bfs/en/home/statistics/catalogues-databases/tables.assetdetail.9486043.html.
  3. Bundesamt für Statistik. Sterbeziffern für 30 wichtige Todesursachen nach Geschlecht [Internet]. [cited 2020 Jan 09]. Available from: https://www.bfs.admin.ch/bfs/de/home/statistiken/gesundheit/gesundheitszustand/sterblichkeit-todesursachen/spezifische.assetdetail.11348828.html.
  4. Snozzi P, Blank PR, Szucs TD. Stroke in Switzerland: social determinants of treatment access and cost of illness. J Stroke Cerebrovasc Dis. 2014;23(5):926–32. doi:.https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.07.042
  5. Glozier N, Hackett ML, Parag V, Anderson CS ; Auckland Regional Community Stroke (ARCOS) Study Group. The influence of psychiatric morbidity on return to paid work after stroke in younger adults: the Auckland Regional Community Stroke (ARCOS) Study, 2002 to 2003. Stroke. 2008;39(5):1526–32. doi:.https://doi.org/10.1161/STROKEAHA.107.503219
  6. Ekker MS, Verhoeven JI, Vaartjes I, Jolink WMT, Klijn CJM, de Leeuw FE. Association of Stroke Among Adults Aged 18 to 49 Years With Long-term Mortality. JAMA. 2019;321(21):2113–23. doi:.https://doi.org/10.1001/jama.2019.6560
  7. Sacco RL, Kasner SE, Broderick JP, Caplan LR, Connors JJ, Culebras A, et al.; American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Council on Nutrition, Physical Activity and Metabolism. An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44(7):2064–89. doi:.https://doi.org/10.1161/STR.0b013e318296aeca
  8. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, et al.; American Heart Association; American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Interdisciplinary Council on Peripheral Vascular Disease. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40(6):2276–93. doi:.https://doi.org/10.1161/STROKEAHA.108.192218
  9. Matis GK, Chrysou OI, Birbilis TA. Organizational issues in stroke treatment: The Swiss paradigm - Stroke units. J Neurosci Rural Pract. 2013;4(S 01, Suppl 1):S131–3. doi:.https://doi.org/10.4103/0976-3147.116450
  10. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP ; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7. doi:.https://doi.org/10.1016/S0140-6736(07)61602-X
  11. Lyrer PM, Arnold M, Hungerbühler H, Gralla J, Humm A, Fandino J, et al. Stroke Units und Stroke Centers in der Schweiz. Richtlinien und Anforderungsprofil. Swiss Medical Forum. 2012;12(47):918–22. doi:.https://doi.org/10.4414/smf.2012.01293
  12. Adams HP, Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24(1):35–41. doi:.https://doi.org/10.1161/01.STR.24.1.35
  13. Brott T, Adams HP, Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20(7):864–70. doi:.https://doi.org/10.1161/01.STR.20.7.864
  14. Johnston SC, Rothwell PM, Nguyen-Huynh MN, Giles MF, Elkins JS, Bernstein AL, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet. 2007;369(9558):283–92. doi:.https://doi.org/10.1016/S0140-6736(07)60150-0
  15. Simons LA, McCallum J, Friedlander Y, Simons J. Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke. 1998;29(7):1341–6. doi:.https://doi.org/10.1161/01.STR.29.7.1341
  16. Kajitani N, Uchida HA, Suminoe I, Kakio Y, Kitagawa M, Sato H, et al. Chronic kidney disease is associated with carotid atherosclerosis and symptomatic ischaemic stroke. J Int Med Res. 2018;46(9):3873–83. doi:.https://doi.org/10.1177/0300060518781619
  17. Meschia JF, Bushnell C, Boden-Albala B, Braun LT, Bravata DM, Chaturvedi S, et al.; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; Council on Functional Genomics and Translational Biology; Council on Hypertension. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(12):3754–832. doi:.https://doi.org/10.1161/STR.0000000000000046
  18. Berner Stroke Netzwerks. Stroke Richtlinien. 2018. Available from: http://www.neurologie.insel.ch/de/unser-angebot/stroke-center/stroke-richtlinien/
  19. Duncan MS, Freiberg MS, Greevy RA, Jr, Kundu S, Vasan RS, Tindle HA. Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease. JAMA. 2019;322(7):642–50. doi:.https://doi.org/10.1001/jama.2019.10298
  20. Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957;2(5):200–15. doi:.https://doi.org/10.1177/003693305700200504
  21. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–7. doi:.https://doi.org/10.1161/01.STR.19.5.604
  22. Langhorne P, Stott DJ, Robertson L, MacDonald J, Jones L, McAlpine C, et al. Medical complications after stroke: a multicenter study. Stroke. 2000;31(6):1223–9. doi:.https://doi.org/10.1161/01.STR.31.6.1223
  23. Schweizerische Herzstiftung. Hirnschlagkampagne: Ein Hirnschlag kann jeden treffen, jederzeit [cited 2020 July 07]. Available from: https://www.swissheart.ch/de/ueber-uns/kampagnen/hirnschlagkampagne.html
  24. O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al.; INTERSTROKE investigators. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–75. doi:.https://doi.org/10.1016/S0140-6736(16)30506-2
  25. Lachkhem Y, Rican S, Minvielle É. Understanding delays in acute stroke care: a systematic review of reviews. Eur J Public Health. 2018;28(3):426–33. doi:.https://doi.org/10.1093/eurpub/cky066
  26. Sekoranja L, Griesser AC, Wagner G, Njamnshi AK, Temperli P, Herrmann FR, et al. Factors influencing emergency delays in acute stroke management. Swiss Med Wkly. 2009;139(27-28):393–9. doi:.https://doi.org/10.4414/smw.2009.12506
  27. Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al.; Stroke Thrombolysis Trialists’ Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384(9958):1929–35. doi:.https://doi.org/10.1016/S0140-6736(14)60584-5
  28. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al.; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359(13):1317–29. doi:.https://doi.org/10.1056/NEJMoa0804656
  29. Reeves MJ, Bushnell CD, Howard G, Gargano JW, Duncan PW, Lynch G, et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 2008;7(10):915–26. doi:.https://doi.org/10.1016/S1474-4422(08)70193-5
  30. Meyre P, Conen D, Osswald S, Kühne M, Meyer-Zürn C. Atrial fibrillation for internists: current practice. Swiss Med Wkly. 2020;150:w20196. doi:.https://doi.org/10.4414/smw.2020.20196
  31. Odden MC, Pletcher MJ, Coxson PG, Thekkethala D, Guzman D, Heller D, et al. Cost-effectiveness and population impact of statins for primary prevention in adults aged 75 years or older in the United States. Ann Intern Med. 2015;162(8):533–41. doi:.https://doi.org/10.7326/M14-1430
  32. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al.; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–81. doi:.https://doi.org/10.1093/eurheartj/ehw106
  33. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al.; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373–498. doi:.https://doi.org/10.1093/eurheartj/ehaa612
  34. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al.; Authors/Task Force Members; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis. 2019;290:140–205. doi:.https://doi.org/10.1016/j.atherosclerosis.2019.08.014
  35. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Rev Esp Cardiol (Engl Ed). 2019;72(2):160. doi:.https://doi.org/10.1016/j.rec.2018.12.004
  36. Wiegand N, Lüthy R, Vogel B, Straumann E, Beynon C, Bertel O, et al. Intravenous thrombolysis for acute ischaemic stroke in a hospital without a specialised neuro-intensive care unit. Swiss Med Wkly. 2004;134(1-2):14–7. doi:.https://doi.org/10.1093/eurheartj/ehaa612
  37. Kamal N, Sheng S, Xian Y, Matsouaka R, Hill MD, Bhatt DL, et al. Delays in Door-to-Needle Times and Their Impact on Treatment Time and Outcomes in Get With The Guidelines-Stroke. Stroke. 2017;48(4):946–54. doi:.https://doi.org/10.1161/STROKEAHA.116.015712
  38. Tong X, Wiltz JL, George MG, Odom EC, Coleman King SM, Chang T, et al.; Paul Coverdell National Acute Stroke Program team. A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017. Circ Cardiovasc Qual Outcomes. 2018;11(12):e004981. doi:.https://doi.org/10.1161/CIRCOUTCOMES.118.004981
  39. Xian Y, Xu H, Lytle B, Blevins J, Peterson ED, Hernandez AF, et al. Use of Strategies to Improve Door-to-Needle Times With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke in Clinical Practice: Findings from Target: Stroke. Circ Cardiovasc Qual Outcomes. 2017;10(1):e003227. doi:.https://doi.org/10.1161/CIRCOUTCOMES.116.003227
  40. Man S, Xian Y, Holmes DN, Matsouaka RA, Saver JL, Smith EE, et al. Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients With Acute Ischemic Stroke. JAMA. 2020;323(21):2170–84. doi:.https://doi.org/10.1001/jama.2020.5697
  41. Kepplinger J, Barlinn K, Deckert S, Scheibe M, Bodechtel U, Schmitt J. Safety and efficacy of thrombolysis in telestroke: A systematic review and meta-analysis. Neurology. 2016;87(13):1344–51. doi:.https://doi.org/10.1212/WNL.0000000000003148
  42. Meretoja A, Strbian D, Mustanoja S, Tatlisumak T, Lindsberg PJ, Kaste M. Reducing in-hospital delay to 20 minutes in stroke thrombolysis. Neurology. 2012;79(4):306–13. doi:.https://doi.org/10.1212/WNL.0b013e31825d6011
  43. Wu TY, Coleman E, Wright SL, Mason DF, Reimers J, Duncan R, et al. Helsinki Stroke Model Is Transferrable With “Real-World” Resources and Reduced Stroke Thrombolysis Delay to 34 min in Christchurch. Front Neurol. 2018;9:290. doi:.https://doi.org/10.3389/fneur.2018.00290
  44. Jeon SB, Ryoo SM, Lee DH, Kwon SU, Jang S, Lee EJ, et al. Multidisciplinary Approach to Decrease In-Hospital Delay for Stroke Thrombolysis. J Stroke. 2017;19(2):196–204. doi:.https://doi.org/10.5853/jos.2016.01802
  45. Van Schaik SM, Van der Veen B, Van den Berg-Vos RM, Weinstein HC, Bosboom WMJ. Achieving a door-to-needle time of 25 minutes in thrombolysis for acute ischemic stroke: a quality improvement project. J Stroke Cerebrovasc Dis. 2014;23(10):2900–6. doi:.https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.07.025
  46. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–418. doi:.https://doi.org/10.1161/STR.0000000000000211
  47. Strbian D, Ahmed N, Wahlgren N, Lees KR, Toni D, Roffe C, et al.; SITS Investigators. Trends in Door-to-Thrombolysis Time in the Safe Implementation of Stroke Thrombolysis Registry: Effect of Center Volume and Duration of Registry Membership. Stroke. 2015;46(5):1275–80. doi:.https://doi.org/10.1161/STROKEAHA.114.007170
  48. Kamal N, Shand E, Swanson R, Hill MD, Jeerakathil T, Imoukhuede O, et al. Reducing Door-to-Needle Times for Ischaemic Stroke to a Median of 30 Minutes at a Community Hospital. Can J Neurol Sci. 2019;46(1):51–6. doi:.https://doi.org/10.1017/cjn.2018.368
  49. Bovim MR, Askim T, Lydersen S, Fjærtoft H, Indredavik B. Complications in the first week after stroke: a 10-year comparison. BMC Neurol. 2016;16(1):133. doi:.https://doi.org/10.1186/s12883-016-0654-8
  50. Ingeman A, Andersen G, Hundborg HH, Svendsen ML, Johnsen SP. In-hospital medical complications, length of stay, and mortality among stroke unit patients. Stroke. 2011;42(11):3214–8. doi:.https://doi.org/10.1161/STROKEAHA.110.610881
  51. Hinchey JA, Shephard T, Furie K, Smith D, Wang D, Tonn S ; Stroke Practice Improvement Network Investigators. Formal dysphagia screening protocols prevent pneumonia. Stroke. 2005;36(9):1972–6. doi:.https://doi.org/10.1161/01.STR.0000177529.86868.8d
  52. Jørgensen HS, Nakayama H, Raaschou HO, Vive-Larsen J, Støier M, Olsen TS. Outcome and time course of recovery in stroke. Part II: Time course of recovery. The Copenhagen Stroke Study. Arch Phys Med Rehabil. 1995;76(5):406–12. doi:.https://doi.org/10.1016/S0003-9993(95)80568-0
  53. Hankey GJ, Spiesser J, Hakimi Z, Bego G, Carita P, Gabriel S. Rate, degree, and predictors of recovery from disability following ischemic stroke. Neurology. 2007;68(19):1583–7. doi:.https://doi.org/10.1212/01.wnl.0000260967.77422.97

Most read articles by the same author(s)